摘要
Background and Aim Programmed cell death-ligand 1 (PD-L1) immunohistochemistry score has been approved as the predictive biomarker for anti-PD1/PD-L1 therapy in several advanced malignancies. Although its predictive role remained inconclusive in hepatocellular carcinoma, ongoing study of anti-PD1/PD-L1 therapy showed promising results. However, less is known about the PD-L1 immunohistochemistry score and factors correlated with it in hepatocellular carcinoma. We investigated PD-L1 immunohistochemistry scores in a large cohort of hepatocellular carcinoma, as well as its correlation with various clinical and genomic factors. @@@ Methods Immunohistochemistry was performed to detect the expression of PD-L1 protein in 315 hepatocellular carcinoma tissues. All slides were independently reviewed by three senior pathologists. Next-generation YS panel (450 genes) sequencing was performed on 309 patients. @@@ Results Higher PD-L1 expression as measured by combined positive score (CPS) was associated with increased Edmondson-Steiner grade (grade III vs II, P = 0.041) and TP53 mutations (P = 0.021). PD-L1 CPS had no correlation with tumor mutational burden (Spearman's correlation coefficient 0.067). PD-L1 CPS was not significantly associated with hepatitis B virus infection. @@@ Conclusions Our data indicated that patients with higher Edmondson-Steiner grade (grade III) had significantly higher PD-L1 CPS than patients with lower Edmondson-Steiner grade (grade II). Patients with TP53 mutations had significantly higher PD-L1 expression.
学科与关键词
- PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response ActivityGuo, Shuang; Wang, Xinyue; Zhou, Hanxiao; Gao, Yue; Wang, Peng; Zhi, Hui; Sun, Yue; Zhang, Yakun; Gan, Jing; Xiao, Yun*; Ning, Shangwei*Biomolecules, 2022, 12(9): 1226.被引 4
- Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung CancerLi, Yue; Li, Chong; Jiang, Ya; Han, Xue; Liu, Sisi; Xu, Xiuxiu; Tang, Wanxiangfu; Ou, Qiuxiang; Bao, Hua; Wu, Xue; Shao, Yang; Xing, Minyan; Zhang, Yixiang*; Wang, Yuezhen*Journal of Oncology, 2022, 2022: 1763778.被引 1
- Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer PatientsChen, Xinhua; Zhang, Huimin; Wang, Minghao; Liu, Hao; Hu, Yanfeng; Lin, Tian; Chen, Hao; Zhao, Mingli; Chen, Tao; Li, Guoxin; Yu, Jiang*; Zhao, Liying*Frontiers in Immunology, 2022, 13: 783695.被引 7
